McKesson Corporation Litigation - Private class action ($350 million settlement) - Municipal class action ($82 million settlement) - Multiple state attorney general actions were favorably resolved
AWP Litigation Represented classes of consumers and third-party payors in a ground-breaking pharmaceutical fraud case where the court approved a total of $338 million in settlements.
Opioids Litigation Representing the Orange County District Attorney’s office in a case alleging five pharmaceutical companies orchestrated a false and misleading marketing scheme designed to reverse the popular and medical understanding of the serious risks of long-term opioid use for chronic, non-cancer pain.
Fannie Mae/Freddie Mac Takings Litigation Representing shareholders in the Court of Federal Claims alleging that, in imposing the conservatorships over Fannie Mae and Freddie Mac in September 2008, the Government took private property without just compensation.
ATM Antitrust Litigation Representing consumers challenging illegal agreements among Visa, MasterCard and member banks to charge inflated ATM access fees, in violation of the federal antitrust laws.
Qui Tam matters Currently working on numerous qui tam matters that are under seal in multiple jurisdictions.
Robert M. Roseman, partner, chairs the Firm's international and domestic securities practice group. Mr. Roseman focuses his practice on investor protection issues, including the enforcement of the federal securities laws and state laws involving fiduciary duties of directors and officers, and under the laws in the various jurisdictions in Europe where group actions can be brought. An important component of his practice involves protecting U.S. and European investors in European proceedings. In that role, he works with U.S. and European institutional investors on investor protection and corporate governance matters.